Huan‐Xin Lin
- Cancer Research top 2%
- Breast Cancer Treatment Studies 26
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 21
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis 13
- Lung Cancer Research Studies 10
-
- Gastric Cancer Management and Outcomes 8
-
- Breast Lesions and Carcinomas 18
-
- Breast Implant and Reconstruction 10
- Esophageal Cancer Research and Treatment 8
- Partner nations
- ChinaGermanyUnited Kingdom
In The Last Decade
Huan‐Xin Lin
96 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 94
- Cancer Research 745
- Otorhinolaryngology 173
- Oncology 854
- Pulmonary and Respiratory Medicine 465
- Pathology and Forensic Medicine 233
Countries citing papers authored by Huan‐Xin Lin
This map shows the geographic impact of Huan‐Xin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huan‐Xin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huan‐Xin Lin more than expected).
Fields of papers citing papers by Huan‐Xin Lin
This network shows the impact of papers produced by Huan‐Xin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huan‐Xin Lin. The network helps show where Huan‐Xin Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huan‐Xin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 23 | |
| 5 | 2023 | 1 | |
| 6 | A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer | 2022 | 20 |
| 7 | 2020 | 7 | |
| 8 | 2019 | 13 | |
| 9 | 2016 | 6 | |
| 10 | 2015 | 16 | |
| 11 | 2015 | 23 | |
| 12 | 2015 | 35 | |
| 13 | 2014 | 38 | |
| 14 | 2014 | 10 | |
| 15 | 2014 | 27 | |
| 16 | 2012 | 129 | |
| 17 | 2012 | 23 | |
| 18 | 2010 | 11 | |
| 19 | 2010 | 1 | |
| 20 | 2009 | 1 |
About Huan‐Xin Lin
Huan‐Xin Lin is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 97 papers that have together received 2.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (26 papers), Head and Neck Cancer Studies (21 papers), Breast Lesions and Carcinomas (18 papers), Inflammatory Biomarkers in Disease Prognosis (13 papers), Breast Implant and Reconstruction (10 papers), Lung Cancer Research Studies (10 papers), Esophageal Cancer Research and Treatment (8 papers) and Gastric Cancer Management and Outcomes (8 papers). The work is most often cited by research in Cancer Research (745 citations), Otorhinolaryngology (173 citations) and Oncology (854 citations). Huan‐Xin Lin has collaborated with scholars based in China, Germany and United Kingdom. Frequent co-authors include Zhen‐Yu He, Jiayuan Sun, San‐Gang Wu, Libing Song, Ling Guo, Qin Lin, Feng-Yan Li, Feng‐Yan Li, Xin Hua and Ling Guo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.